Search hospitals > California > Santa Rosa
Sutter Pacific Medical Foundation
Claim this profileSanta Rosa, California 95403
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Relapse
Conducts research for Stomach Cancer
Conducts research for Lung Cancer
124 reported clinical trials
9 medical researchers
Summary
Sutter Pacific Medical Foundation is a medical facility located in Santa Rosa, California. This center is recognized for care of Skin Cancer, Breast Cancer, Relapse, Stomach Cancer, Lung Cancer and other specialties. Sutter Pacific Medical Foundation is involved with conducting 124 clinical trials across 311 conditions. There are 9 research doctors associated with this hospital, such as Ari Baron, MD, Christopher Jones, Deepti Behl, and Kristie A. Bobolis.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Ari Baron, MDAlta Bates Summit Medical Center-Herrick Campus8 years of reported clinical research
Expert in Skin Cancer
Studies Non-Small Cell Lung Cancer
30 reported clinical trials
68 drugs studied
Christopher JonesSutter Medical Center Sacramento4 years of reported clinical research
Studies Skin Cancer
Studies Brain Tumor
26 reported clinical trials
69 drugs studied
Deepti BehlCalifornia Pacific Medical Center-Pacific Campus5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
50 drugs studied
Kristie A. BobolisSutter Medical Center Sacramento1 year of reported clinical research
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
24 drugs studied
Clinical Trials running at Sutter Pacific Medical Foundation
Breast Cancer
Skin Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Breast cancer
Kidney Cancer
Stomach Cancer
Pancreatic Cancer
Squamous Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sutter Pacific Medical Foundation?
Sutter Pacific Medical Foundation is a medical facility located in Santa Rosa, California. This center is recognized for care of Skin Cancer, Breast Cancer, Relapse, Stomach Cancer, Lung Cancer and other specialties. Sutter Pacific Medical Foundation is involved with conducting 124 clinical trials across 311 conditions. There are 9 research doctors associated with this hospital, such as Ari Baron, MD, Christopher Jones, Deepti Behl, and Kristie A. Bobolis.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.